NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 324 filers reported holding NEOGENOMICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,241,026 | -23.4% | 139,454 | -17.0% | 0.01% | -20.0% |
| Q1 2023 | $2,924,184 | +60.9% | 167,960 | -20.4% | 0.01% | +42.9% |
| Q3 2022 | $1,817,000 | -13.7% | 210,992 | -18.4% | 0.01% | -12.5% |
| Q2 2022 | $2,106,000 | +28.4% | 258,443 | +91.4% | 0.01% | +60.0% |
| Q1 2022 | $1,640,000 | -36.2% | 134,999 | +79.2% | 0.01% | -28.6% |
| Q4 2021 | $2,570,000 | -23.8% | 75,331 | +7.8% | 0.01% | -30.0% |
| Q3 2021 | $3,371,000 | +6.9% | 69,886 | +0.1% | 0.01% | 0.0% |
| Q2 2021 | $3,152,000 | -6.9% | 69,791 | -0.6% | 0.01% | -16.7% |
| Q1 2021 | $3,385,000 | -15.1% | 70,193 | -5.3% | 0.01% | -14.3% |
| Q4 2020 | $3,989,000 | +37.4% | 74,085 | -5.9% | 0.01% | +16.7% |
| Q3 2020 | $2,904,000 | +13.6% | 78,724 | -4.6% | 0.01% | +9.1% |
| Q2 2020 | $2,556,000 | -1.2% | 82,519 | -11.9% | 0.01% | -15.4% |
| Q1 2020 | $2,587,000 | -5.6% | 93,708 | 0.0% | 0.01% | +30.0% |
| Q4 2019 | $2,741,000 | +37.9% | 93,708 | -9.9% | 0.01% | +25.0% |
| Q3 2019 | $1,988,000 | – | 104,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
| Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
| First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
| PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
| Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
| FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
| EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
| Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |